Rare disease care pathways profile in France: leveraging hospital big data to characterize natural history in osteogenesis imperfecta

Marked regression of calcinosis with canakinumab in hyperphosphatemic familial tumoral calcinosis

Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism

Improved Oral Health in Adults With X-Linked Hypophosphatemia Treated With Burosumab

Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancer

Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia

Daily or intermittent vitamin D supplementation in patients with or at risk of osteoporosis: Position statement from the GRIO

Association between osteoporosis and periodontitis

Successful Burosumab Treatment in an Adult Patient with X-Linked Hypophosphatemia and Chronic Kidney Disease Stage 3b

High rate of progression to symptomatic multiple myeloma in patients with smoldering myeloma and isolated osteoporotic vertebral fracture

Recommendations for the optimal use of bone forming agents in osteoporosis

Metabolically healthy obesity in adults with X-linked hypophosphatemia

X-linked hypophosphataemia

The sacroiliac joint: An original and highly sensitive tool to highlight altered bone phenotype in murine models of skeletal disorders

Development of Spinal Enthesopathies in Adults With X-linked Hypophosphatemia

Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

Osteogenesis Imperfecta: characterization of fractures during pregnancy and post-partum

Barriers and Expectations for Patients in Post-Osteoporotic Fracture Care in France: The EFFEL Study

Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scans

Pregnancy rates and outcomes in early axial spondyloarthritis: An analysis of the DESIR cohort

The Causes of Hypo- and Hyperphosphatemia in Humans

Contribution of imaging to the diagnosis and follow up of X-linked hypophosphatemia

Changes in bone formation regulator biomarkers in early axial spondyloarthritis

Bone mineral density at extremely low weight in patients with anorexia nervosa

2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older

Adult rheumatologic features, treatment and complications of X-linked hypophosphatemia

X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience

Impact of Early Conventional Treatment on Adult Bone and Joints in a Murine Model of X-Linked Hypophosphatemia

[Osteoporosis: treatments indications and role of general practitioner]

Absence of association between inflammatory dietary pattern and low trauma fractures: Results of the French cohort NutriNet-Santé

[Drug-induced osteoporosis]

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry

Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data

Real-World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study

Prevalence of Enthesopathies in Adults With X-linked Hypophosphatemia: Analysis of Risk Factors

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Real-World Effectiveness of Osteoporosis Medications in France: A Nationwide Cohort Study

Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analysis of the DESIR cohort

Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data

X-linked hypophosphatemia, a genetic and treatable cause of rickets!

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis

Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description

Health-related quality of life in French adults with X-linked hypophosphatemia: real-world data from the International XLH Registry

Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

METHOFRACT, a methotrexate osteopathy multicentre cohort study

Does delayed weight bearing in the surgical management of fractures of the upper end of the femur in the elderly lead to more complications? A prospective study

Magnetic resonance imaging is a valuable tool to evaluate the therapeutic efficacy of burosumab in children with X-linked hypophosphatemia

High persistence over two years with denosumab among postmenopausal women with osteoporosis in France: A prospective cohort study

Medication for bone loss in female patients with anorexia nervosa: a systematic review and management algorithm

Medication for bone loss in female patients with anorexia nervosa: a systematic review and management algorithm

Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides

Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa

Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides